Artal Group S.A.
Latest statistics and disclosures from Artal Group S.A.'s latest quarterly 13F-HR filing:
- Top 5 stock holdings are WW, BABA, XLRN, BNTX, ALNY, and represent 33.42% of Artal Group S.A.'s stock portfolio.
- Added to shares of these 10 stocks: BABA (+$68.07M), QURE (+$54.57M), BAC (+$42.46M), BDTX (+$42.33M), XBI (+$38.72M), SDGR (+$38.70M), XLI (+$35.41M), XLRN (+$26.96M), MA (+$24.16M), FOLD (+$23.10M).
- Started 24 new stock positions in IMAB, LPTX, APTX, TRIL, RIGL, PTLA, PASG, VNET, XLI, XBI. ARWR, ADVM, MA, SDGR, BAC, AUPH, STOK, QURE, BDTX, PRNB, TCOM, SYRS, MLCO, PRVL.
- Reduced shares in these 10 stocks: MS (-$102.24M), MRNA (-$63.08M), BNTX (-$23.36M), XNCR (-$18.91M), DRNA (-$11.02M), NKTR (-$10.79M), RETA (-$10.22M), , AGIO (-$7.10M), NIO (-$7.04M).
- Sold out of its positions in DRNA, DOYU, IGMS, INCY, NTLA, KRTX, LGF.A, MS, NIO, NKTR. RETA, SGMO, D Stemline Therapeutics, REAL, TWST, VKTX, XNCR.
- Artal Group S.A. was a net buyer of stock by $356.07M.
- Artal Group S.A. has $2.37B in assets under management (AUM), dropping by -8.58%.
Portfolio Holdings for Artal Group S.A.
Companies in the Artal Group S.A. portfolio as of the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Ww Intl Inc (WW) | 10.59 | 14.82M | 16.91 | |
| Alibaba Group Holding Ltd Spon (BABA) | 6.58 | 800.00k | +77% | 194.48 |
| Acceleron Pharma (XLRN) | 5.70 | 1.50M | +25% | 89.87 |
| Biontech Se sponsored ads (BNTX) | 5.50 | 2.23M | -15% | 58.40 |
| Alnylam Pharmaceuticals (ALNY) | 5.06 | 1.10M | +10% | 108.85 |
| Lexicon Pharmaceuticals (LXRX) | 4.96 | 60.24M | 1.95 | |
| Moderna Inc (MRNA) | 3.80 | 3.00M | -41% | 29.95 |
| Beigene (BGNE) | 3.38 | 650.00k | 123.11 | |
| Argenx Se (ARGX) | 2.64 | 475.00k | +35% | 131.73 |
| Avantor Inc (AVTR) | 2.38 | 4.50M | -5% | 12.49 |
| Amicus Therapeutics (FOLD) | 2.34 | 6.00M | +71% | 9.24 |
| Uniqure Nv shs (QURE) | 2.31 | 1.15M | NEW | 47.45 |
| Fate Therapeutics (FATE) | 1.97 | 2.10M | -4% | 22.21 |
| Bank of America Corporation (BAC) | 1.79 | 2.00M | NEW | 21.23 |
| Black Diamond Therapeutics Inc (BDTX) | 1.79 | 1.70M | NEW | 24.95 |
| Paypal Holdings (PYPL) | 1.78 | 440.00k | +120% | 95.74 |
| Epizyme (EPZM) | 1.67 | 2.55M | +13% | 15.51 |
| SPDR S&P Biotech (XBI) | 1.64 | 500.00k | NEW | 77.44 |
| Schrodinger Inc Com stock (SDGR) | 1.64 | 897.45k | NEW | 43.12 |
| Industrial SPDR (XLI) | 1.50 | 600.00k | NEW | 59.01 |
| Blueprint Medicines (BPMC) | 1.48 | 600.00k | +20% | 58.48 |
| Deciphera Pharmaceuticals Inc (DCPH) | 1.39 | 800.00k | +220% | 41.17 |
| Zillow Group Inc Cl C Cap Stk stock (Z) | 1.37 | 900.00k | +20% | 36.02 |
| Scholar Rock Hldg Corp (SRRK) | 1.30 | 2.55M | 12.11 | |
| Morphic Hldg Inc Com (MORF) | 1.13 | 1.82M | 14.68 | |
| MasterCard Incorporated (MA) | 1.02 | 100.00k | NEW | 241.56 |
| Iovance Biotherapeutics (IOVA) | 0.95 | 750.00k | +50% | 29.93 |
| Atara Biotherapeutics (ATRA) | 0.90 | 2.50M | +42% | 8.51 |
| Fibrogen (FGEN) | 0.88 | 600.00k | +50% | 34.75 |
| Gossamer Bio Inc (GOSS) | 0.78 | 1.81M | +12% | 10.15 |
| Rubius Therapeutics Inc (RUBY) | 0.73 | 3.88M | +37% | 4.45 |
| Arrowhead Pharmaceuticals (ARWR) | 0.73 | 600.00k | NEW | 28.77 |
| BioMarin Pharmaceutical (BMRN) | 0.71 | 200.00k | +100% | 84.50 |
| Bridgebio Pharma Inc (BBIO) | 0.67 | 550.00k | +175% | 29.00 |
| Principia Biopharma Inc (PRNB) | 0.63 | 250.00k | NEW | 59.38 |
| Agios Pharmaceuticals (AGIO) | 0.60 | 400.00k | -33% | 35.48 |
| Harpoon Therapeutics Inc (HARP) | 0.59 | 1.20M | +41% | 11.58 |
| 21vianet Group Inc Adr adr (VNET) | 0.59 | 1.00M | NEW | 13.86 |
| Turning Point Therapeutics I (TPTX) | 0.57 | 300.00k | 44.66 | |
| Ascendis Pharma A S (ASND) | 0.48 | 100.00k | 112.61 | |
| Uber Technologies Inc Com (UBER) | 0.47 | 400.00k | -20% | 27.92 |
| Trip Com Intl Ltd Sponsored Ad (TCOM) | 0.46 | 465.00k | NEW | 23.45 |
| Aurinia Pharmaceuticals (AUPH) | 0.46 | 750.00k | NEW | 14.51 |
| Y Mabs Therapeutics Inc (YMAB) | 0.44 | 400.00k | 26.10 | |
| Sage Therapeutics (SAGE) | 0.42 | 350.00k | +133% | 28.72 |
| Tg Therapeutics (TGTX) | 0.42 | 1.00M | +53% | 9.84 |
| Albireo Pharma (ALBO) | 0.41 | 588.12k | +30% | 16.37 |
| Clovis Oncology (CLVS) | 0.40 | 1.50M | -14% | 6.36 |
| Springworks Therapeutics Inc (SWTX) | 0.40 | 350.00k | 27.00 | |
| Denali Therapeutics Inc. (DNLI) | 0.37 | 500.00k | +25% | 17.51 |
| Stoneco Ltd (STNE) | 0.37 | 400.00k | 21.77 | |
| Aravive Inc (ARAV) | 0.35 | 1.45M | +7% | 5.76 |
| Selecta Biosciences (SELB) | 0.35 | 3.41M | 2.41 | |
| Regenxbio Inc equity us cm (RGNX) | 0.34 | 250.00k | +72% | 32.38 |
| Tricida Inc (TCDA) | 0.33 | 360.00k | 22.00 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.30 | 1.30M | 5.49 | |
| Ac Immune Sa shs (ACIU) | 0.29 | 1.00M | 6.91 | |
| Hookipa Pharma Inc equity (HOOK) | 0.28 | 796.26k | -20% | 8.25 |
| Melco Crown Entertainment (MLCO) | 0.26 | 500.00k | NEW | 12.40 |
| Agenus (AGEN) | 0.26 | 2.50M | 2.45 | |
| American Airls (AAL) | 0.26 | 500.00k | 12.19 | |
| Merus N V (MRUS) | 0.26 | 500.00k | 12.10 | |
| Alector Inc (ALEC) | 0.25 | 250.00k | +11% | 24.13 |
| Minerva Neurosciences (NERV) | 0.25 | 1.00M | 6.02 | |
| Translate Bio Inc (TBIO) | 0.25 | 600.00k | -7% | 9.97 |
| Replimune Group Inc (REPL) | 0.25 | 600.00k | 9.97 | |
| Adverum Biotechnologies (ADVM) | 0.25 | 600.00k | NEW | 9.77 |
| Stoke Therapeutics Inc (STOK) | 0.24 | 250.00k | NEW | 22.90 |
| Adaptive Biotechnologies Cor (ADPT) | 0.23 | 200.00k | +33% | 27.78 |
| Accelr8 Technology (AXDX) | 0.21 | 600.00k | 8.33 | |
| Cyclerion Therapeutics Inc (CYCN) | 0.21 | 1.86M | +36% | 2.65 |
| Spero Therapeutics Inc (SPRO) | 0.20 | 576.00k | +15% | 8.08 |
| Bluebird Bio (BLUE) | 0.19 | 100.00k | 45.96 | |
| I Mab Sponsored Ads (IMAB) | 0.19 | 350.00k | NEW | 13.00 |
| Krystal Biotech Inc (KRYS) | 0.18 | 100.00k | +25% | 43.24 |
| Solid Biosciences (SLDB) | 0.18 | 1.80M | 2.39 | |
| 111 Inc ads (YI) | 0.18 | 650.00k | 6.61 | |
| Trillium Therapeutics, Inc. Cmn (TRIL) | 0.17 | 1.00M | NEW | 4.04 |
| Kura Oncology (KURA) | 0.17 | 400.00k | 9.95 | |
| Passage Bio Inc (PASG) | 0.17 | 250.00k | NEW | 15.75 |
| Immunic Inc (IMUX) | 0.16 | 630.02k | 6.05 | |
| Aptinyx Inc (APTX) | 0.15 | 1.67M | NEW | 2.16 |
| Akebia Therapeutics (AKBA) | 0.14 | 425.00k | 7.58 | |
| Prothena (PRTA) | 0.14 | 300.00k | 10.70 | |
| Tcr2 Therapeutics Inc cs (TCRR) | 0.13 | 400.00k | 7.74 | |
| Kaleido Biosciences Ord (KLDO) | 0.13 | 500.50k | 6.15 | |
| Orchard Therapeutics Plc ads (ORTX) | 0.13 | 400.00k | +14% | 7.53 |
| Syros Pharmaceuticals (SYRS) | 0.13 | 506.14k | NEW | 5.93 |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.13 | 500.00k | 5.99 | |
| Aduro Biotech (ADRO) | 0.12 | 1.00M | 2.74 | |
| Prevail Therapeutics Ord (PRVL) | 0.10 | 200.00k | NEW | 12.19 |
| Axcella Health Inc equity (AXLA) | 0.09 | 600.00k | +33% | 3.42 |
| Aeglea Biotherapeutics (AGLE) | 0.08 | 400.00k | +33% | 4.66 |
| Portola Pharmaceuticals (PTLA) | 0.06 | 200.00k | NEW | 7.13 |
| Ironwood Pharmaceuticals (IRWD) | 0.05 | 110.53k | 10.09 | |
| Curis Inc (CRIS) | 0.04 | 1.50M | 0.70 | |
| Rigel Pharmaceuticals (RIGL) | 0.02 | 350.00k | NEW | 1.56 |
| Leap Therapeutics (LPTX) | 0.02 | 250.00k | NEW | 1.58 |
Download CSV 
Past Filings by Artal Group S.A.
View past SEC 13F filings by Artal Group S.A.
- Artal Group S.A. 2019 Q4 filed Feb. 13, 2020
- Artal Group S.A. 2019 Q2 filed Aug. 9, 2019
- Artal Group S.A. 2019 Q1 filed May 10, 2019
- Artal Group S.A. 2018 Q4 filed Feb. 11, 2019
- Artal Group S.A. 2018 Q3 filed Nov. 9, 2018
- Artal Group S.A. 2018 Q2 filed Aug. 10, 2018
- Artal Group S.A. 2018 Q1 filed May 10, 2018
- Artal Group S.A. 2017 Q4 filed Feb. 9, 2018
- Artal Group S.A. 2017 Q3 filed Nov. 8, 2017
- Artal Group S.A. 2017 Q2 filed Aug. 11, 2017
- Artal Group S.A. 2017 Q1 filed May 15, 2017
- Artal Group S.A. 2016 Q4 filed Feb. 14, 2017
- Artal Group S.A. 2016 Q3 filed Nov. 14, 2016
- Artal Group S.A. 2016 Q2 filed Aug. 11, 2016
- Artal Group S.A. 2016 Q1 filed May 12, 2016
- Artal Group S.A. 2015 Q4 filed Feb. 12, 2016
- Artal Group S.A. 2015 Q3 filed Nov. 13, 2015
- Artal Group S.A. 2015 Q2 filed Aug. 13, 2015
- Artal Group S.A. 2015 Q1 filed May 13, 2015